(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

INIBIDORES DE QUINASE DEPENDENTE DE CICLINA (CDK) 12 E/OU CDK13 E USOS DOS MESMOS

Em AnáliseInvention PatentPCT · CN2023111521
Talk to an expert

Application data

Invention Patent INIBIDORES DE QUINASE DEPENDENTE DE CICLINA (CDK) 12 E/OU CDK13 E USOS DOS MESMOS de INSILICO MEDICINE IP LIMITED — IPC A61K 31/505
Invention Patent INIBIDORES DE QUINASE DEPENDENTE DE CICLINA (CDK) 12 E/OU CDK13 E USOS DOS MESMOS de INSILICO MEDICINE IP LIMITED — IPC A61K 31/505. Drawing published by the INPI in the Industrial Property Gazette.

Number

112025002288

Type

Invention Patent

Filing

08/07/2023

Publication

07/22/2025

PCT

CN2023111521
View on INPI

Progress at the INPI

  1. Filing08/07/23
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 08/07/2023. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 07/22/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

INSILICO MEDICINE IP LIMITED

CN

See this company's full portfolio

Inventors

F. R. (pessoa física)

CN

H. L. (pessoa física)

CN

J. W. (pessoa física)

CN

M. Z. (pessoa física)

CN

Y. L. (pessoa física)

CN

Technical data

IPC Classification

A61K 31/505A61K 31/519A61P 35/00C07D 403/14C07D 471/12C07D 487/12

Priority claims

CN

PCT/CN2022/110858 · 08/08/2022

CN

PCT/CN2022/130631 · 11/08/2022

CN

PCT/CN2023/080498 · 03/09/2023

CN

PCT/CN2023/083161 · 03/22/2023

CN

PCT/CN2023/107019 · 07/12/2023

Abstract

INIBIDORES DE QUINASE DEPENDENTE DE CICLINA (CDK) 12 E/OU CDK13 E USOS DOS MESMOS. São descritos aqui inibidores de quinase dependente de ciclina (CDK) 12 e/ou CDK13 (e composições farmacêuticas compreendendo os inibidores. Os compostos e composições em questão são úteis para o tratamento de uma doença ou distúrbio associado à superexpressão de CDK 12 e/ou CDK13.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

07/22/2025

RPI 2846

Alteração de dados cadastrais

#1.1

02/18/2025

RPI 2824

Related

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.